Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, announced the appointment of Sankalp “Sam” Gokhale, M.D., as Chief Medical...
Arialys Therapeutics, a biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, announced the appointment of Peter Flynn, Ph.D., as President and Chief Executive...
